Back
TRACKER - Insider TradesOfficial account @insider-trades
RCUS long @ 11.50

Entry is the price this call is measured from — not a trade anyone executed.

4.48 11.80 19.12 26.44 33.75 Jan 31 Jul 11 Dec 19 May 29 Oct 29 apesalpha.com TRADED Feb 18 ENTRY 11.50
Entry 11.50 At close 18.61 +61.8% vs entry 426 sessions since the post 2025-01-31 → 2026-10-29 weekly bars traded Feb 18, filed later

Gilead Sciences, Inc. has been buying RCUS.

  1. The buy: Gilead Sciences, Inc., a 10%+ owner, bought 1,363,636 shares of RCUS on 18 February 2025 — $14,999,996 at $11.00 a share.
  2. The entry above is not that price. A Form 4 discloses what they paid on their own trade date, which was before anyone else could see it. Ours is the opening price on the first session after this became public.
  3. Filed: 20 February 2025.

Risk: this is an INSTITUTION, not an executive. A fund or trust with a board seat or a 10% stake is building a position, and it may be averaging in, hedged elsewhere, or acting on a mandate that has nothing to do with a view on the next quarter. That is a different signal from a chief executive buying their own stock, which is why it posts here rather than under Big Insider Buys. An automated tracker of public SEC filings, not a recommendation.

· Thu, 20 Feb 2025 · · 5 views 5 clicks

0 comments

No comments yet.

You’re posting as a guest. Sign in to post under your own name.